163 related articles for article (PubMed ID: 19888795)
1. Cost effectiveness of facility-based care, home-based care and mobile clinics for provision of antiretroviral therapy in Uganda.
Babigumira JB; Sethi AK; Smyth KA; Singer ME
Pharmacoeconomics; 2009; 27(11):963-73. PubMed ID: 19888795
[TBL] [Abstract][Full Text] [Related]
2. The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda.
Marseille E; Kahn JG; Pitter C; Bunnell R; Epalatai W; Jawe E; Were W; Mermin J
Appl Health Econ Health Policy; 2009; 7(4):229-43. PubMed ID: 19905037
[TBL] [Abstract][Full Text] [Related]
3. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.
Badri M; Cleary S; Maartens G; Pitt J; Bekker LG; Orrell C; Wood R
Antivir Ther; 2006; 11(1):63-72. PubMed ID: 16518961
[TBL] [Abstract][Full Text] [Related]
4. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
5. Economics of switching to second-line antiretroviral therapy with lopinavir/ritonavir in Africa: estimates based on DART trial results and costs for Uganda and Kenya.
Simpson KN; Baran RW; Kirbach SE; Dietz B
Value Health; 2011 Dec; 14(8):1048-54. PubMed ID: 22152173
[TBL] [Abstract][Full Text] [Related]
6. Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness.
Bassett IV; Govindasamy D; Erlwanger AS; Hyle EP; Kranzer K; van Schaik N; Noubary F; Paltiel AD; Wood R; Walensky RP; Losina E; Bekker LG; Freedberg KA
PLoS One; 2014; 9(1):e85197. PubMed ID: 24465503
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti.
Koenig SP; Bang H; Severe P; Jean Juste MA; Ambroise A; Edwards A; Hippolyte J; Fitzgerald DW; McGreevy J; Riviere C; Marcelin S; Secours R; Johnson WD; Pape JW; Schackman BR
PLoS Med; 2011 Sep; 8(9):e1001095. PubMed ID: 21949643
[TBL] [Abstract][Full Text] [Related]
8. Bringing antiretroviral therapy (ART) closer to the end-user through mobile clinics and home-based ART: systematic review shows more evidence on the effectiveness and cost effectiveness is needed.
Mdege ND; Chindove S
Int J Health Plann Manage; 2014; 29(1):e31-e47. PubMed ID: 23606314
[TBL] [Abstract][Full Text] [Related]
9. Potential cost-effectiveness of universal access to modern contraceptives in Uganda.
Babigumira JB; Stergachis A; Veenstra DL; Gardner JS; Ngonzi J; Mukasa-Kivunike P; Garrison LP
PLoS One; 2012; 7(2):e30735. PubMed ID: 22363480
[TBL] [Abstract][Full Text] [Related]
10. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study.
Kahn JG; Marseille E; Moore D; Bunnell R; Were W; Degerman R; Tappero JW; Ekwaru P; Kaharuza F; Mermin J
BMJ; 2011 Nov; 343():d6884. PubMed ID: 22074713
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.
Medina Lara A; Kigozi J; Amurwon J; Muchabaiwa L; Nyanzi Wakaholi B; Mujica Mota RE; Walker AS; Kasirye R; Ssali F; Reid A; Grosskurth H; Babiker AG; Kityo C; Katabira E; Munderi P; Mugyenyi P; Hakim J; Darbyshire J; Gibb DM; Gilks CF;
PLoS One; 2012; 7(4):e33672. PubMed ID: 22545079
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adults.
Bachmann MO
AIDS Care; 2006 Feb; 18(2):109-20. PubMed ID: 16338768
[TBL] [Abstract][Full Text] [Related]
13. Economic analysis of bevacizumab, cetuximab, and panitumumab with fluoropyrimidine-based chemotherapy in the first-line treatment of KRAS wild-type metastatic colorectal cancer (mCRC).
Lawrence D; Maschio M; Leahy KJ; Yunger S; Easaw JC; Weinstein MC
J Med Econ; 2013 Dec; 16(12):1387-98. PubMed ID: 24102083
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis.
Cleary SM; McIntyre D; Boulle AM
Cost Eff Resour Alloc; 2006 Dec; 4():20. PubMed ID: 17147833
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness analysis of routine use of genotypic antiretroviral resistance testing after failure of antiretroviral treatment for HIV.
Corzillius M; Mühlberger N; Sroczynski G; Jaeger H; Wasem J; Siebert U
Antivir Ther; 2004 Feb; 9(1):27-36. PubMed ID: 15040534
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age.
Ciaranello AL; Doherty K; Penazzato M; Lindsey JC; Harrison L; Kelly K; Walensky RP; Essajee S; Losina E; Muhe L; Wools-Kaloustian K; Ayaya S; Weinstein MC; Palumbo P; Freedberg KA
AIDS; 2015 Jun; 29(10):1247-59. PubMed ID: 25870982
[TBL] [Abstract][Full Text] [Related]
17. Opportunities for improving the efficiency of paediatric HIV treatment programmes.
Revill PA; Walker S; Mabugu T; Nathoo KJ; Mugyenyi P; Kekitinwa A; Munderi P; Bwakura-Dangarembizi M; Musiime V; Bakeera-Kitaka S; Nahirya-Ntege P; Walker AS; Sculpher MJ; Gibb DM
AIDS; 2015 Jan; 29(2):201-10. PubMed ID: 25396263
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of facility and home based HIV voluntary counseling and testing strategies in rural Uganda.
Mulogo EM; Batwala V; Nuwaha F; Aden AS; Baine OS
Afr Health Sci; 2013 Jun; 13(2):423-9. PubMed ID: 24235945
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.
Berto P; Ronco C; Cruz D; Melotti RM; Antonelli M
Blood Purif; 2011; 32(4):331-40. PubMed ID: 22086346
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of group psychotherapy for depression in Uganda.
Siskind D; Baingana F; Kim J
J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
